Clinical cases of extrapulmonary manifestations in patients with coronavirus disease (COVID-19)

• Published in: Patolohii͡a Vol. 19; no. 2; pp. 160 - 165
• Main Authors: Riabokon, O. V., Pak, К. А., Furyk, О. О., Cherkaskyi, V. V.
• Format: Journal Article
• Language: English
• Published: Zaporozhye State Medical University 01.10.2022
• Subjects: coronavirus disease covid-19; extrapulmonary manifestations; treatment; viral infection
• ISSN: 2306-8027; 2310-1237
• DOI: 10.14739/2310-1237.2022.2.257403

The aim of the work – to provide variants of extrapulmonary manifestations of coronavirus disease (COVID-19) based on the analysis of the relevant course of the disease in adults. Results. The paper presents two clinical cases of coronavirus disease (COVID-19) with the manifestation of extrapulmonary symptoms, which required some individualization of therapy. The first clinical observation showed that in a 56-year-old patient with moderate COVID-19, the development of oxygen dependence on the 8th day of the disease was combined with the manifestation of extrapulmonary symptoms in the form of cutaneous manifestations. Individualization of glucocorticosteroid therapy and endothelioprotective therapy has been shown to be effective in regressing both oxygen dependence and cutaneous vasculitis. The second clinical observation showed that in a 35-year-old patient, moderate COVID-19 without oxygen dependence was accompanied by the development of extrapulmonary manifestations, namely short-lasting diarrheal syndrome, which manifested in the onset of the disease and of the development of orchiepididymitis on the 9th day of illness, which required the appointment of anti-inflammatory therapy. Conclusions. The abovementioned clinical observations of COVID-19 cases show relatively rare cases of SARS-CoV-2- associated extrapulmonary manifestations in patients with moderate disease, but their development necessitated individualization of treatment.